Kymriah (tisagenlecleucel) was approved for relapsed/refractory ALL in 2017, but its label covers use in children and young adults aged up to 25, who account for the bulk of cases of the blood cancer.

‘If I am finished now, I can finish a happy man, knowing my kids saw me play and will remember’ ...

Gain insights, see trends and get real-time updates when you securely link or manually add your brokerage accounts.

Sign Up for Wine Spectator’s Free Email Newsletters and stay up-to-date with all things wine.

All titles are available on both DVD and Blu-ray unless otherwise noted.